Product Name | MF | CAS | Details |
---|
Anti-ENTK antibody produced in rabbit | Details |
(1S,3R,3AS,7AR)-3-ALLYL-5-{[TERT-BUTYL(DIPHENYL)SILYL]OXY}-1,3,3A,4,5,7A-HEXAHYDRO-2-BENZOFURAN-1-CARBONITRILE | C28H33NO2Si | 1217494-10-4 | Details |
2-((E)-{2-[8-((2E)-2-{2-[(4-CHLOROBENZOYL)OXY]BENZYLIDENE}HYDRAZINO)-8-OXOOCTANOYL]HYDRAZONO}METHYL)PHENYL 4-CHLOROBENZOATE | C36H32Cl2N4O6 | 374684-68-1 | Details |
Silicone O-ring + Plug Seal | Details |
Anti-PCP4L1 antibody produced in rabbit | Details |
5-(4,6-DIHYDROXY-2-(PROPIONYLAMINO)-5-PYRIMIDINYL)PENTANOIC ACID | 78423-21-9 | Details |
WHEATON? liquid scintillation vial with attached foamed PE lined PP cap | Details |
2-BENZOYL-3-(4-HYDROXY-PHENYL)-ACRYLONITRILE | C16H11NO2 | 20412-91-3 | Details |
(R)-()-2-Phenylbutyric acid | C10H12O2 | 938-79-4 | Details |
(5,6-DIHYDRO-BENZO(C)ACRIDIN-7-YL)-DIISOPROPYL-AMINE, DI-HYDROBROMIDE | 1172844-80-2 | Details |
4-(2-((4-BROMOANILINO)(OXO)AC)CARBOHYDRAZONOYL)-2-MEO-PH 3,4-DICHLOROBENZOATE | C23H16BrCl2N3O5 | 881460-47-5 | Details |
1-(2-THIAZOLYL)-3-(3,4-XYLYL)UREA | 200561-95-1 | Details |
N-(3,4-DICHLORO-PHENYL)-2-HYDROXY-6-METHOXY-BENZAMIDE | 883802-63-9 | Details |
Arachidonyl- |
Details |
3-Nitro-L-tyrosine-13C9 | Details |
(E)-Cyclooct-4-enol | C8H14O | 85081-69-2 | Details |
Biotinamidohexanoyl-6-aminohexanoic acid N-hydroxysuccinimide ester | C26H41N5O7S | 89889-52-1 | Details |
(3-HYDROXYMETHYL-NAPHTHALEN-2-YL)-METHANOL | C12H12O2 | 31554-15-1 | Details |
1-(4-CHLOROPHENYL)-2-HYDROXY-2-(4-NITROPHENYL)-1H,2H,3H,5H,6H,7H,8H,9H-IMIDAZO[1,2-A]AZEPIN-4-IUM BROMIDE | C20H21ClN3O3.Br | 352200-19-2 | Details |
METHYL 6-O-[TERT-BUTYL(DIPHENYL)SILYL]-2,4-DIDEOXY-3-O-(4-METHOXYBENZYL)-2-METHYL-BETA-D-XYLO-HEXOPYRANOSIDE | 215317-55-8 | Details |
4-[4-(ALLYLOXY)-3-METHYLBENZOYL]-3-HYDROXY-5-(4-ISOPROPYLPHENYL)-1-[3-(4-MORPHOLINYL)PROPYL]-1,5-DIHYDRO-2H-PYRROL-2-ONE | C31H38N2O5 | 442551-20-4 | Details |
2′-Deoxyadenosine 5′-triphosphate disodium salt | C10H17N5NaO12P3 | 74299-50-6 | Details |
Anti-GRID2 antibody produced in rabbit | Details |
2-[(2-FURYLMETHYL)AMINO]-3-{(Z)-[3-(4-METHOXYBENZYL)-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-5-YLIDENE]METHYL}-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE | C25H20N4O4S2 | 608494-67-3 | Details |
SNAP i.d. Starter Bundle-Mini | Details |
Steritest? Symbio FLEX Pump | Details |
2,2'-AZOXYBIPHENYL | C24H18N2O | 7334-10-3 | Details |
Sevoflurane Related Compound C | C3H2F6O | 920-66-1 | Details |
Perdeuterated PAH-II solution in hexane/toluene | Details |
2-METHYLCYCLOHEXYL N-(2-ETHYL-6-METHYLPHENYL)CARBAMATE | 200634-59-9 | Details |
1-(4-CHLORO-PHENYL)-4-METHYL-3-PHENYL-1H-PYRAZOLE | 1003988-52-0 | Details |
Rheumatoid Factor Removal Reagent (1 mL) | Details |
955, CDK9 PROTAC trifluoroacetate | Details |
Np# HCl | Details |
3-Chloro-4-ethoxyphenylboronic acid | C8H10BClO3 | 279261-81-3 | Details |
JEG3 | Details |
N-(2-(2-(4-CHLOROBENZYLIDENE)HYDRAZINO)-2-OXOETHYL)DODECANAMIDE | C21H32ClN3O2 | 880042-62-6 | Details |
PrEST Antigen SLC29A3 | Details |
(2-OXO-BENZOTHIAZOL-3-YL)-ACETIC ACID 4-ALLYL-2-METHOXY-PHENYL ESTER | 154184-40-4 | Details |
1-((3AS,3A1R,3B1R,E)-3A-METHYL-3,3A,3A1,3B1,6,7-HEXAHYDRO-2H-INDEN-4-YL)ETHANONE | C14H18O | 1217463-60-9 | Details |
2-(BENZYLAMINO)-N-(5-METHYL-3-ISOXAZOLYL)ACETAMIDE HYDROCHLORIDE | C13H15N3O2.ClH | 1134758-97-6 | Details |
N-(2-(2-((2-CL-7-ME-3-QUINOLINYL)METHYLENE)HYDRAZINO)-2-OXOETHYL)DODECANAMIDE | C25H35ClN4O2 | 880050-64-6 | Details |
9-CL-2-(4-CL-PH)-5-(2,3-DI-MEO-PH)-1,10B-DIHYDROPYRAZOLO(1,5-C)(1,3)BENZOXAZINE | C24H20Cl2N2O3 | 883820-25-5 | Details |
PHENYLTRICHLOROTELLURIUM | 29510-67-6 | Details |
GASKET, 2 SEALS KIT, PROMAG H, DN40,EPDM | Details |
N-(4-METHOXY-2-NITRO-PHENYL)-2-P-TOLYLSULFANYL-ACETAMIDE | C16H16N2O4S | 331461-12-2 | Details |
Anti-ZBTB38 | Details |
ETHYL 3-(4-NITROBENZOYL)BENZO(F)PYRROLO(1,2-A)QUINOLINE-1-CARBOXYLATE | C26H18N2O5 | 70654-03-4 | Details |
Monoclonal Anti-CD35-APC antibody produced in mouse | Details |
3-(4-FLUOROPHENYL)-N'-((2-HO-1-NAPHTHYL)METHYLENE)-1H-PYRAZOLE-5-CARBOHYDRAZIDE | 402504-73-8 | Details |
4-BROMO-BENZENESULFONIC ACID 2,3-DIPHENYL-PROPYL ESTER | 883835-46-9 | Details |
16,17-ACETONIDE 21-CYCLOPROPANECARBOXYLATE | Details |
Anti-CASP9 (CLEAVED-ASP353), C-Terminal antibody produced in rabbit | Details |
SUPELCOSIL LC-8 HPLC Column | Details |
Anti-TBPL2 antibody produced in rabbit | Details |
7-(3-BROMOBENZYL)-8-(DIETHYLAMINO)-3-METHYL-3,7-DIHYDRO-1H-PURINE-2,6-DIONE | C17H20BrN5O2 | 476480-95-2 | Details |
Boc-Ala-ONp | C14H18N2O6 | 2483-49-0 | Details |
Diphenylamine-4-sulfonic acid barium salt | C12H13BaNO3S | 6211-24-1 | Details |
3,4-DICHLOROBENZOIC N2-(2-PHENYLACETYL)HYDRAZIDE | 198067-25-3 | Details |
Toxin B, Clostridium difficile | Details |
ChemiSCREEN Human PAC1-long Receptor Membrane Preparation | Details |
5-CHLORO-N-(2-CHLORO-5-NITROBENZYLIDENE)-2,4-DIMETHOXY-ANILINE | C15H12Cl2N2O4 | 196712-07-9 | Details |
N-(1,2-BIS(2-FLUOROPHENYL)-2-(2-FLUOROBENZYLIDENEAMINO)ETHYL)-2-FLUOROBENZAMIDE | C28H20F4N2O | 195531-74-9 | Details |
2-(3-METHOXY-BENZYLIDENE)-MALONONITRILE | C11H8N2O | 2972-72-7 | Details |
2,4,6-Trimethylpyridinium p-toluenesulfonate | C15H19NO3S | 59229-09-3 | Details |
2-{[4-(4-CHLOROPHENYL)-5-PHENYL-4H-1,2,4-TRIAZOL-3-YL]SULFANYL}-N'-[(E)-(3-ETHOXY-4-HYDROXYPHENYL)METHYLIDENE]ACETOHYDRAZIDE | C25H22ClN5O3S | 315199-99-6 | Details |
(5-Isopropyl-1,2,4-oxadiazol-3-yl)methanol | C6H10N2O2 | 915924-67-3 | Details |
DIPHENYL 4,4'-METHYLENEDICARBANILATE | C27H22N2O4 | 101-65-5 | Details |
Anti-CARS Antibody, clone 7V0X1, Rabbit Monoclonal | Details |
Diisopropyl-13C6 ether | C6H14O | 1173021-65-2 | Details |
Derivatizing agents, Set for GC: Alcohols with boron trifluoride | Details |
Enzastaurin | C32H29N5O2 | 170364-57-5 | Details |
Membrane Scaffold Protein 1E3D1 | Details |
Anti-CBR1 antibody produced in rabbit | Details |
Monoclonal Anti-CD25-PE antibody produced in mouse | Details |
2-(2-(2-(ALLYLOXY)BENZYLIDENE)HYDRAZINO)-N-(2-CHLOROPHENYL)-2-OXOACETAMIDE | C18H16ClN3O3 | 765311-63-5 | Details |
Tiotropium for system suitability 1 | C19H24BrNO5S2 | 411207-31-3 | Details |
3-(1-ADAMANTYL)-N'-[(3E)-5-BROMO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE]-1H-PYRAZOLE-5-CARBOHYDRAZIDE | C22H22BrN5O2 | 306300-34-5 | Details |
ETHYL 1-(4-BROMOBENZOYL)-7-METHYLPYRROLO(1,2-A)QUINOLINE-3-CARBOXYLATE | C23H18BrNO3 | 302913-65-1 | Details |
N-(2-CHLOROETHYL)-BENZYLAMINE HCL | C9H13Cl2N | 6288-63-7 | Details |
1,4-Dihydro-6-methylquinoxaline-2,3-dione | C9H8N2O2 | 6309-61-1 | Details |
N-(4-FLUOROBENZYLIDENE)-3-(TRIFLUOROMETHYL)ANILINE | C14H9F4N | 198879-66-2 | Details |
2-[(5Z)-5-(2-CHLOROBENZYLIDENE)-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-3-YL]-3-PHENYLPROPANOIC ACID | C19H14ClNO3S2 | 304674-51-9 | Details |
N-(2-METHOXY-5-NITROPHENYL)-2-METHYLPROPANAMIDE | C11H14N2O4 | 330469-45-9 | Details |
(1,1'-BIPHENYL)-4-YL 4-CHLOROBENZOATE | C19H13ClO2 | 300675-67-6 | Details |
Metronidazole-OH | C6H9N3O4 | 4812-40-2 | Details |
2,4-BIS(3-METHYL-2(3H)BENZOTHIAZOLYLIDENEMETHYL)13CYCLOBUTADIENEDIYLIUM13DIOLATE | C22H18N2O2S2 | 883840-17-3 | Details |
1-(BENZOYL)-4-PHENYLSEMICARBAZIDE | C14H13N3O2 | 1152-32-5 | Details |
Desthiobiotin polyethyleneoxide Iodoacetamide | C21H38I1N5O6 | Details |
4-(((5-ME-2-FURYL)METHYLENE)AMINO)-5-(3-METHYLPHENYL)-4H-1,2,4-TRIAZOLE-3-THIOL | C15H14N4OS | 478255-92-4 | Details |
1,2-CYCLOHEXANEDICARBOXYLIC ACID MONO-ETHYL ESTER | C10H16O4 | 67805-22-5 | Details |
ETHYL (2Z)-2-(1-ALLYL-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)-7-METHYL-3-OXO-5-[(E)-2-PHENYLETHENYL]-2,3-DIHYDRO-5H-[1,3]THIAZOLO[3,2-A]PYRIMIDINE-6-CARBOXYLATE | C29H25N3O4S | 624726-62-1 | Details |
GM6001 MMP Inhibitor | Details |
N-(4-CHLOROPHENYL)-2-{(3Z)-3-[3-(4-METHYLBENZYL)-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-5-YLIDENE]-2-OXO-2,3-DIHYDRO-1H-INDOL-1-YL}ACETAMIDE | C27H20ClN3O3S2 | 618075-39-1 | Details |
2-AMINO-4-[5-ETHYL-2-(ETHYLSULFANYL)-3-THIENYL]-7,7-DIMETHYL-5-OXO-1-(3-PYRIDINYL)-1,4,5,6,7,8-HEXAHYDRO-3-QUINOLINECARBONITRILE | C25H28N4OS2 | 476483-43-9 | Details |
3-(2-FURYL)-N-(1,3-THIAZOL-2-YL)-2-PROPENAMIDE | C10H8N2O2S | 853407-23-5 | Details |
Ace evaporating flask, pear-shaped | Details |
4-BENZYL-N-(2-CHLORO-3-PHENYL-2-PROPENYLIDENE)-1-PIPERAZINAMINE | C20H22ClN3 | 307328-39-8 | Details |
2-HYDROXY-1-(4-METHOXYPHENYL)-2-(3-NITROPHENYL)-1H,2H,3H,5H,6H,7H,8H,9H-IMIDAZO[1,2-A]AZEPIN-4-IUM BROMIDE | C21H24BrN3O4 | 352200-25-0 | Details |
4-CHLORO-N'-PHENYLBENZOHYDRAZIDE | C13H11ClN2O | 15089-07-3 | Details |
Product Total: Product Page: | ||||
384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 |